Similarly, when we repeated the dose–response analyses including individuals with a history of thyroid disease or intake of thyroid hormones before the first screening, the EOR/Gy was 0.09 (95% CI, 0.03 to 0.17). This evidence concerns the gene TG and thyroid gland disorder.